文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

胰十二指肠切除联合门静脉/肠系膜上静脉汇合部切除后的左侧门静脉高压:系统综述

Left-sided portal hypertension after pancreatoduodenectomy with resection of the portal/superior mesenteric vein confluence. Results of a systematic review.
PubMed 文献 · Surgery · 2020-06-27

该系统综述纳入8项研究共829例患者,评估胰十二指肠切除联合门静脉/肠系膜上静脉汇合部切除后左侧门静脉高压的发生率、治疗与预防策略。脾静脉保留者左侧门静脉高压发生率为7.7%,脾静脉结扎者为29.4%。左侧门静脉高压相关消化道出血虽罕见,但可依据情况采用内镜、放射学操作或手术干预处理,相关死亡率低。

要点

  • 脾静脉结扎未重建者左侧门静脉高压发生率高于脾静脉保留者。
  • 左侧门静脉高压相关消化道出血平均发生于术后28个月。
  • 治疗包括脾切除、结肠切除及内镜、放射学或保守治疗。

核心结论

  • 左侧门静脉高压是胰十二指肠切除联合静脉切除后潜在严重的并发症,脾静脉结扎未重建时发生率更高。
  • 左侧门静脉高压相关消化道出血虽罕见,但可依据情况通过内镜、放射学操作或手术干预处理,相关死亡率低。

研究设计与样本

  • 系统综述,遵循PRISMA声明检索截至2019年9月30日发表的文献。
  • 共纳入8篇文章,包括829例患者。

主要发现

  • 脾静脉保留者左侧门静脉高压发生率为7.7%,脾静脉结扎者为29.4%。
  • 1个月相关死亡率为7.1%。
  • 治疗包括脾切除3例(21%)、结肠切除1例(7%),其余病例(71%)采用放射学、内镜操作或保守治疗有效。

临床怎么用

  • 胰十二指肠切除联合门静脉/肠系膜上静脉汇合部切除时,应关注左侧门静脉高压风险,脾静脉结扎未重建者风险更高。
  • 术后出现消化道出血需考虑左侧门静脉高压,可依据情况选择内镜、放射学操作或手术干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatoduodenectomy with synchronous resection of the portal vein/superior mesenteric vein confluence may result in the development of left-sided portal hypertension. Left-sided portal hypertension presents with splenomegaly and varices and may cause severe gastrointestinal bleeding. The aim of the study is to review the incidence, treatment, and preventive strategies of left-sided portal hypertension. METHODS: A systematic literature search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement to identify all studies published up to September 30, 2019 reporting data on patients with left-sided portal hypertension after pancreatoduodenectomy with venous resection. RESULTS: Eight articles including 829 patients were retrieved. Left-sided portal hypertension occurred in 7.7% of patients who had splenic vein preservation and 29.4% of those having splenic vein ligation. Fourteen cases of gastrointestinal bleeding owing to left-sided portal hypertension were reported at a mean interval of 28 months from pancreatoduodenectomy. Related mortality at 1 month was 7.1%. Treatment of left-sided portal hypertension consisted of splenectomy in 3 cases (21%) and colectomy in 1 (7%) case, whereas radiologic, endoscopic procedures or conservative treatments were effective in the other cases (71%). CONCLUSION: Left-sided portal hypertension represents a potentially severe complication of pancreatoduodenectomy with venous resection occurring at greater incidence when the splenic vein is ligated and not reimplanted. Left-sided portal hypertension-related gastrointestinal bleeding although rare can be managed depending on the situation by endoscopic, radiologic procedures or operative intervention with low related mortality.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Petrucciani N, Debs T, Rosso E, et al. Left-sided portal hypertension after pancreatoduodenectomy with resection of the portal/superior mesenteric vein confluence. Results of a systematic review. Surgery. 2020. PMID: 32600882. doi:10.1016/j.surg.2020.04.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。